[go: up one dir, main page]

DK0382276T3 - Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer - Google Patents

Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer

Info

Publication number
DK0382276T3
DK0382276T3 DK90200167.6T DK90200167T DK0382276T3 DK 0382276 T3 DK0382276 T3 DK 0382276T3 DK 90200167 T DK90200167 T DK 90200167T DK 0382276 T3 DK0382276 T3 DK 0382276T3
Authority
DK
Denmark
Prior art keywords
indazole
hydroxymethyl
ethers
benzyl
aliphatic
Prior art date
Application number
DK90200167.6T
Other languages
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK0382276T3 publication Critical patent/DK0382276T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90200167.6T 1989-02-07 1990-01-23 Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer DK0382276T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
DK0382276T3 true DK0382276T3 (da) 1996-01-15

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90200167.6T DK0382276T3 (da) 1989-02-07 1990-01-23 Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer

Country Status (36)

Country Link
US (2) US4999367A (da)
EP (1) EP0382276B1 (da)
JP (1) JP2870925B2 (da)
KR (1) KR0145525B1 (da)
CN (2) CN1046505C (da)
AR (1) AR247386A1 (da)
AT (1) ATE127115T1 (da)
AU (1) AU624895B2 (da)
BG (1) BG50273A3 (da)
CA (1) CA2009503C (da)
CZ (1) CZ280121B6 (da)
DD (2) DD295363A5 (da)
DE (2) DE382276T1 (da)
DK (1) DK0382276T3 (da)
EG (1) EG19170A (da)
ES (1) ES2020171T3 (da)
FI (1) FI102678B (da)
GE (1) GEP19971030B (da)
GR (2) GR910300073T1 (da)
HU (1) HU204793B (da)
IL (1) IL93132A (da)
IN (1) IN170957B (da)
IT (1) IT1230441B (da)
LT (1) LT3604B (da)
LV (1) LV10612B (da)
NZ (1) NZ232258A (da)
PE (1) PE25091A1 (da)
PH (1) PH26552A (da)
PL (2) PL163720B1 (da)
PT (1) PT93067B (da)
RO (1) RO106252B1 (da)
RU (3) RU2066318C1 (da)
SK (1) SK278441B6 (da)
UA (1) UA26852C2 (da)
YU (1) YU47943B (da)
ZA (1) ZA90644B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
PT2254869T (pt) 2008-03-07 2017-07-18 Acraf Novos derivados de 1-benzil-3-hidroximetilindazole e suas utilizações no tratamento de doenças com base na expressão de cx3cr1 e p40
AU2009221063B2 (en) 2008-03-07 2013-03-21 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, and CX3CR1
MX2010009625A (es) 2008-03-07 2010-09-28 Acraf Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
CA2766235C (en) 2009-08-03 2017-04-04 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.S.P.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1h-indazole and its derivatives and required magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
JP2015523546A (ja) 2012-05-01 2015-08-13 トランスレイタム メディカス インコーポレイテッド 失明性疾患を処置および診断するための方法
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP2850062B1 (en) 2012-05-18 2017-07-19 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
JP6257596B2 (ja) 2012-05-18 2018-01-10 サノフイ ピラゾール誘導体およびlpar5アンタゴニストとしてのその使用
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
EP0382276A3 (en) 1990-12-12
LTIP872A (en) 1995-03-27
AU4906690A (en) 1990-08-16
CN1044810A (zh) 1990-08-22
PL163730B1 (pl) 1994-04-29
GR910300073T1 (en) 1991-11-15
GR3018165T3 (en) 1996-02-29
JP2870925B2 (ja) 1999-03-17
SK56390A3 (en) 1997-05-07
IT1230441B (it) 1991-10-23
RU2066318C1 (ru) 1996-09-10
CN1034016C (zh) 1997-02-12
HU204793B (en) 1992-02-28
LV10612B (en) 1995-08-20
KR0145525B1 (ko) 1998-08-17
IT8947620A0 (it) 1989-02-07
FI900577A0 (fi) 1990-02-06
EP0382276A2 (en) 1990-08-16
ES2020171A4 (es) 1991-08-01
CA2009503C (en) 2000-04-11
IL93132A0 (en) 1990-11-05
LT3604B (en) 1995-12-27
US5112986A (en) 1992-05-12
DD291995A5 (de) 1991-07-18
ES2020171T3 (es) 1995-12-01
JPH02240065A (ja) 1990-09-25
IL93132A (en) 1994-05-30
PH26552A (en) 1992-08-19
RO106252B1 (ro) 1993-03-31
RU2055071C1 (ru) 1996-02-27
HUT53088A (en) 1990-09-28
CA2009503A1 (en) 1990-08-07
CN1046505C (zh) 1999-11-17
US4999367A (en) 1991-03-12
DE382276T1 (de) 1991-11-28
KR900012913A (ko) 1990-09-03
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
EP0382276B1 (en) 1995-08-30
YU20690A (sh) 1992-07-20
NZ232258A (en) 1991-06-25
CZ56390A3 (en) 1995-06-14
SK278441B6 (en) 1997-05-07
ATE127115T1 (de) 1995-09-15
RU2044729C1 (ru) 1995-09-27
PE25091A1 (es) 1991-08-17
AU624895B2 (en) 1992-06-25
UA26852C2 (uk) 1999-12-29
CN1088201A (zh) 1994-06-22
AR247386A1 (es) 1994-12-29
PT93067A (pt) 1990-08-31
LV10612A (lv) 1995-04-20
DD295363A5 (de) 1991-10-31
HU900689D0 (en) 1990-04-28
DE69021902T2 (de) 1996-05-23
DE69021902D1 (de) 1995-10-05
IN170957B (da) 1992-06-20
YU47943B (sh) 1996-07-24
CZ280121B6 (cs) 1995-11-15
ZA90644B (en) 1991-01-30
PT93067B (pt) 1995-12-29
BG50273A3 (en) 1992-06-15
PL163720B1 (pl) 1994-04-29
EG19170A (en) 1994-11-30
FI102678B (fi) 1999-01-29

Similar Documents

Publication Publication Date Title
DK0382276T3 (da) Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer
DK180790A (da) Fremstilling af farmaceutisk praeparat
DK148885D0 (da) Stabilt praeparat af interleukin-2
DK199384D0 (da) Balle af straa eller hoe
AR240408A1 (es) Pelota de basquetbol
DK0485436T3 (da) Fremgangsmåde til fremstilling af et næringsmiddel med reduceret fedtstofindhold
DK196986D0 (da) Fremstilling af polysaccharider
DK0482094T3 (da) Fremgangsmåde til fremstilling af et næringsmiddel med reduceret fedtstofindhold
DK363887A (da) Anvendelse af bromcruptin
DK427787A (da) Komponenter af plastmateriale
DK529583D0 (da) Enzymatisk fremstilling af l-serin
DK141090D0 (da) Fremstilling af human prourokinase
DK420185A (da) Anvendelse af somatostatinanaloge
DK88091D0 (da) Fremstilling af pentansyrederivater
DK0387654T3 (da) Fremgangsmåde til fremstilling af alkylenglycolmonosorbater
DK541487A (da) Sammenfoejning af materialer
DK105089A (da) Fremstilling af bis(amin-holdige)benzendioler
DK73687A (da) Hydroxaminsyrer af 7-oxabicycloheptansubstituerede ethere
DK487289D0 (da) Omestring af phospholipider
DK135387D0 (da) Fremstilling af proteiner
ID1049B (id) Komposisi batangan deterjen
DK519287A (da) Praeparat med thrombolytisk virkning
DK345683D0 (da) Fremstilling af 2-t-butyl-5-chlorpyrimidin
DK321986A (da) Fremstilling af proteiner
DK512687D0 (da) Fremstilling af proteiner